Anoro Ellipta vs. Stiolto Respimat

• Are Anoro Ellipta and Stiolto Respimat he Same Thing?
• What Are Possible Side Effects of Anoro Ellipta?
• What Are Possible Side Effects of Stiolto Respimat?
• What is Anoro Ellipta?
• What is Stiolto Respimat?
• What Drugs Interact with Anoro Ellipta?
• What Drugs Interact with Stiolto Respimat?
• How Should Anoro Ellipta Be Taken?
• How Should Stiolto Respimat Be Taken?

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder and Stiolto Respimat (tiotropium bromide and olodaterol) inhalation spray are combinations of anticholinergics and long acting beta-adrenoceptor agonists (LABAs) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Side effects of Anoro Ellipta and Stiolto Respimat that are similar include sore throat, sinusitis, constipation, cough, gastroesophageal reflux disease (GERD), itching, rash, and palpitations.

Side effects of Anoro Ellipta that are different from Stiolto Respimat include respiratory tract infection, diarrhea, pain in extremities, muscle spasms, neck pain, chest pain or discomfort, indigestion, abdominal pain, vomiting, weakness, irregular heartbeats, conjunctivitis, hypersensitivity reactions including anaphylaxis and hives, changes in taste, tremor, and anxiety.

Side effects of Stiolto Respimat that are different from Anoro Ellipta include back pain, dehydration, dizziness, insomnia, glaucoma, blurred vision, fast heart rate, high blood pressure, nosebleed, difficulty speaking, laryngitis, dry mouth, oral thrush, difficulty swallowing, gum disease, swollen lips or tongue, hives, skin infection, dry skin, joint pain or swelling, urinary retention, difficulty urinating, and urinary tract infection (UTI).

Both Anoro Ellipta and Stiolto Respimat may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta-blockers, diuretics (water pills), and other anticholinergic drugs.

Stiolto Respimat may also interact with other adrenergic drugs, xanthine derivatives, steroids, and drugs that prolong QTc intervals.

Common side effects of Anoro Ellipta include:

• sore throat,
• sinusitis,
• respiratory tract infection,
• constipation,
• diarrhea,
• pain in extremities,
• muscle spasms,
• neck pain,
• chest pain or discomfort,
• cough,
• indigestion,
• abdominal pain,
• gastroesophageal reflux disease (GERD),
• vomiting,
• weakness,
• irregular heart beats,
• itching,
• rash,
• conjunctivitis,
• palpitations,
• hypersensitivity reactions including anaphylaxis and hives,
• changes in taste,
• tremor, and
• anxiety.

Common side effects of Stiolto Respimat include:

• sinus irritation and sore throat (nasopharyngitis),
• cough,
• back pain,
• dehydration,
• dizziness,
• insomnia,
• glaucoma,
• blurred vision,
• palpitations,
• fast heart rate,
• high blood pressure,
• nosebleed,
• difficulty speaking,
• laryngitis,
• sinus infection,
• dry mouth,
• constipation,
• oral thrush,
• difficulty swallowing,
• gastroesophageal reflux disease (GERD),
• gum disease,
• swollen lips or tongue,
• rash,
• itching,
• hives,
• skin infection,
• dry skin,
• joint pain or swelling,
• urinary retention,
• difficulty urinating, and
• urinary tract infection.

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder is a combination anticholinergic and long acting beta-adrenoceptor agonist (LABA) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Stiolto Respimat (tiotropium bromide and olodaterol) inhalation spray is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

Anoro Ellipta may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta blockers, diuretics, and other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Anoro Ellipta should be used only if prescribed. Tell your doctor if you are pregnant before taking Anoro Ellipta or if you become pregnant during treatment. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Stiolto Respimat may interact with other adrenergic drugs, xanthine derivatives, steroids, diuretics, non-potassium sparing diuretics, MAO inhibitors, tricyclic antidepressants, drugs that prolong QTc intervals, beta-blockers, and other anticholinergics. Tell your doctor all medications and supplements you use. During pregnancy, Stiolto Respimat should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Anoro Ellipta is administered as 1 inhalation dose once daily by the orally inhaled route only.

The dose of Stiolto Respimat is two inhalations once-daily at the same time of day.